Zions Bancorporation’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,279
Closed -$883K 868
2024
Q3
$883K Buy
12,279
+1,962
+19% +$138K 0.06% 213
2024
Q2
$715K Sell
10,317
-254
-2% -$18.5K 0.06% 215
2024
Q1
$847K Buy
10,571
+516
+5% +$46K 0.06% 219
2023
Q4
$1.1M Buy
10,055
+685
+7% +$70.8K 0.08% 200
2023
Q3
$945K Buy
+9,370
New +$1.08M 0.08% 194

Other funds holding CNMD

Zions Bancorporation's CNMD Position: Q4 2024 in Review

Zions Bancorporation sold out of CONMED (CNMD) in Q4 2024, closing a stake of 12,279 shares — an estimated $883K sold.

Zions Bancorporation first reported a position in CNMD in Q3 2023 and held it in 5 quarters. The position peaked at $1.1M in Q4 2023. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

  • Zions Bancorporation reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
  • Zions Bancorporation sold 12,279 CONMED shares in Q4 2024, an estimated $883K.
  • Zions Bancorporation first reported a position in CONMED in Q3 2023 and held it in 5 quarters.
  • Zions Bancorporation's CONMED position peaked at $1.1M in Q4 2023.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.